Tongwang Yang

425 total citations
22 papers, 263 citations indexed

About

Tongwang Yang is a scholar working on Molecular Biology, Epidemiology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Tongwang Yang has authored 22 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Epidemiology and 4 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Tongwang Yang's work include Effects and risks of endocrine disrupting chemicals (3 papers), Advanced Nanomaterials in Catalysis (3 papers) and RNA modifications and cancer (3 papers). Tongwang Yang is often cited by papers focused on Effects and risks of endocrine disrupting chemicals (3 papers), Advanced Nanomaterials in Catalysis (3 papers) and RNA modifications and cancer (3 papers). Tongwang Yang collaborates with scholars based in China, Australia and Spain. Tongwang Yang's co-authors include Dexi Chen, Yuxue Gao, Pengxiang Yang, Jiming Yin, Wei Wang, Jiyue Wu, Jie Yang, Xiaoni Liu, Shaowen Huang and Chunhong Liu and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Free Radical Biology and Medicine and Chemosphere.

In The Last Decade

Tongwang Yang

20 papers receiving 260 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tongwang Yang China 10 100 46 36 36 34 22 263
Lin Yu China 10 134 1.3× 48 1.0× 77 2.1× 19 0.5× 49 1.4× 22 292
Lobna Elkhadragy United States 10 158 1.6× 51 1.1× 49 1.4× 11 0.3× 15 0.4× 19 261
Siyu Jia China 8 81 0.8× 31 0.7× 33 0.9× 35 1.0× 16 0.5× 27 225
Ying Xiang China 11 243 2.4× 33 0.7× 24 0.7× 16 0.4× 48 1.4× 17 351
Giancarlo Chesi Italy 7 105 1.1× 21 0.5× 83 2.3× 32 0.9× 17 0.5× 7 365
Tian Li China 11 141 1.4× 45 1.0× 51 1.4× 15 0.4× 35 1.0× 33 352
Austin Read Canada 4 151 1.5× 39 0.8× 9 0.3× 30 0.8× 17 0.5× 5 283
Raman Preet Kaur India 10 138 1.4× 61 1.3× 105 2.9× 15 0.4× 15 0.4× 15 297
Haiguang Xin China 8 89 0.9× 27 0.6× 31 0.9× 74 2.1× 10 0.3× 14 232
Sameerah Shaheen Saudi Arabia 10 137 1.4× 75 1.6× 83 2.3× 26 0.7× 22 0.6× 25 314

Countries citing papers authored by Tongwang Yang

Since Specialization
Citations

This map shows the geographic impact of Tongwang Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tongwang Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tongwang Yang more than expected).

Fields of papers citing papers by Tongwang Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tongwang Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tongwang Yang. The network helps show where Tongwang Yang may publish in the future.

Co-authorship network of co-authors of Tongwang Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Tongwang Yang. A scholar is included among the top collaborators of Tongwang Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tongwang Yang. Tongwang Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Tongwang, et al.. (2025). PINK1 dysfunction in hepatocellular carcinoma fosters immune evasion and disease progression by promoting neutrophil infiltration. Journal for ImmunoTherapy of Cancer. 13(12). e013079–e013079.
2.
Yang, Tongwang, et al.. (2025). Non-parenchymal cells: key targets for modulating chronic liver diseases. Frontiers in Immunology. 16. 1576739–1576739. 1 indexed citations
3.
Xiang, Junyu, Yuanli Ni, Hui Sun, et al.. (2025). MEF2D-expressing cancer precursors reprogram tissue-resident macrophages to support liver tumorigenesis. Nature Cancer. 6(12). 1955–1975.
5.
Zhao, Yang, Tongwang Yang, Yabo Ouyang, et al.. (2024). Radiofrequency ablation plays double role in immunosuppression and activation of PBMCs in recurrent hepatocellular carcinoma. Frontiers in Immunology. 15. 1339213–1339213. 4 indexed citations
6.
Liu, Yuxiang, Xiang Qin, Tongwang Yang, Jing Wang, & Hongde Li. (2023). LINC01806 Promotes Breast Cancer Growth and Metastasis via Sponging miR-1286 to Disinhibit ZEB1 Expression. Biochemical Genetics. 62(3). 1977–1993. 1 indexed citations
7.
Yang, Tongwang, Xianghua Guo, Yanxiang Huang, et al.. (2023). CHB patients with rtA181T‐mutated HBV infection are associated with higher risk hepatocellular carcinoma due to increases in mutation rates of tumour suppressor genes. Journal of Viral Hepatitis. 30(12). 951–958. 16 indexed citations
8.
Gao, Yuxue, Pengxiang Yang, Pengxiang Liu, et al.. (2023). Recent advances in recurrent hepatocellular carcinoma therapy. World Journal of Hepatology. 15(4). 460–476. 13 indexed citations
9.
Wang, Yang, Jiaxi Li, Shanshan Wang, et al.. (2023). The hepatitis B virus promotes the progression of non-alcoholic fatty liver disease through incomplete autophagy. Free Radical Biology and Medicine. 204. 326–336. 7 indexed citations
10.
Yang, Tongwang, et al.. (2023). Unveiling the Mystery of SUMO-activating enzyme subunit 1: A Groundbreaking Biomarker in the Early Detection and Advancement of Hepatocellular Carcinoma. Transplantation Proceedings. 55(4). 945–951. 25 indexed citations
12.
Li, Xinqiang, Shipeng Li, Dahong Teng, et al.. (2022). Landscape of Immune Cells Heterogeneity in Liver Transplantation by Single-Cell RNA Sequencing Analysis. Frontiers in Immunology. 13. 890019–890019. 36 indexed citations
13.
Yang, Tongwang, Yabo Ouyang, Yuxue Gao, et al.. (2020). Enriched high‑throughput reverse transcription‑quantitative PCR template preparation without pre‑amplification. Molecular Medicine Reports. 22(4). 3541–3548. 2 indexed citations
14.
Gao, Yuxue, et al.. (2020). Progress and prospects of biomarkers in�primary liver cancer (Review). International Journal of Oncology. 57(1). 54–66. 64 indexed citations
15.
Huang, Qingyi, Tongwang Yang, Yichao Yang, et al.. (2019). Effects of nonylphenol administration on serum, liver and testis estrogen metabolism. Chemosphere. 235. 543–549. 18 indexed citations
16.
Liu, Dongjie�, Tongwang Yang, Jieling Wang, et al.. (2018). DRAM is Involved in Hypoxia/Ischemia-Induced Autophagic Apoptosis in Hepatocytes. Aging and Disease. 10(1). 82–82. 9 indexed citations
17.
Yang, Tongwang, Yuxue Gao, Daojie Liu, et al.. (2018). ASPP2 enhances chemotherapeutic sensitivity through the down-regulation of XIAP expression in a p53 independent manner in hepatocellular carcinoma. Biochemical and Biophysical Research Communications. 508(3). 769–774. 15 indexed citations
18.
Liu, Chunhong, et al.. (2017). Influence of nonylphenol and octylphenol exposure on 5-HT, 5-HT transporter, and 5-HT2A receptor. Environmental Science and Pollution Research. 24(9). 8279–8286. 11 indexed citations
19.
Liu, Huan, et al.. (2017). Intervention effect of gamma aminobutyric acid on anxiety behavior induced by phthalate (2-ethylhexyl ester) in rats. International Journal of Neuroscience. 128(10). 928–934. 4 indexed citations
20.
Liu, Yang, et al.. (2016). Acute changes in murine hippocampus and olfactory bulb after nasal instillation of varying size cerium dioxide particles. Journal of Toxicology and Environmental Health. 79(19). 869–877. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026